Coexpression cluster:C1714
From FANTOM5_SSTAR
Full id: C1714_Hepatocyte_mature_liver_Synoviocyte_parotid_tenocyte_breast
Phase1 CAGE Peaks
Hg19::chr14:21152706..21152783,+ | p1@ANG p1@RNASE4 |
Hg19::chr4:185726679..185726692,- | p6@ACSL1 |
Hg19::chr4:77227797..77227808,+ | p4@STBD1 |
Hg19::chr4:77227809..77227820,+ | p5@STBD1 |
Hg19::chr4:77227845..77227860,+ | p3@STBD1 |
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
No results for this coexpression
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0032148 | activation of protein kinase B | 0.0104828061310714 |
GO:0032311 | angiogenin-PRI complex | 0.0104828061310714 |
GO:0032429 | regulation of phospholipase A2 activity | 0.0104828061310714 |
GO:0001556 | oocyte maturation | 0.0104828061310714 |
GO:0032431 | activation of phospholipase A2 | 0.0104828061310714 |
GO:0006651 | diacylglycerol biosynthetic process | 0.0104828061310714 |
GO:0032430 | positive regulation of phospholipase A2 activity | 0.0104828061310714 |
GO:0048662 | negative regulation of smooth muscle cell proliferation | 0.0114132670918778 |
GO:0001938 | positive regulation of endothelial cell proliferation | 0.0114132670918778 |
GO:0048599 | oocyte development | 0.0114132670918778 |
GO:0030246 | carbohydrate binding | 0.0114132670918778 |
GO:0046460 | neutral lipid biosynthetic process | 0.0114132670918778 |
GO:0009994 | oocyte differentiation | 0.0114132670918778 |
GO:0046339 | diacylglycerol metabolic process | 0.0114132670918778 |
GO:0046463 | acylglycerol biosynthetic process | 0.0114132670918778 |
GO:0046504 | glycerol ether biosynthetic process | 0.0115088380852527 |
GO:0045017 | glycerolipid biosynthetic process | 0.0115088380852527 |
GO:0004467 | long-chain-fatty-acid-CoA ligase activity | 0.0128709689544981 |
GO:0015645 | fatty-acid ligase activity | 0.0128709689544981 |
GO:0048660 | regulation of smooth muscle cell proliferation | 0.0129699268652264 |
GO:0009303 | rRNA transcription | 0.0129699268652264 |
GO:0005624 | membrane fraction | 0.0129699268652264 |
GO:0048659 | smooth muscle cell proliferation | 0.0129699268652264 |
GO:0001890 | placenta development | 0.0129699268652264 |
GO:0007202 | phospholipase C activation | 0.0129699268652264 |
GO:0050714 | positive regulation of protein secretion | 0.0129699268652264 |
GO:0032501 | multicellular organismal process | 0.0129699268652264 |
GO:0001936 | regulation of endothelial cell proliferation | 0.0129699268652264 |
GO:0048477 | oogenesis | 0.0129699268652264 |
GO:0044255 | cellular lipid metabolic process | 0.0129699268652264 |
GO:0001541 | ovarian follicle development | 0.0129699268652264 |
GO:0030426 | growth cone | 0.0129699268652264 |
GO:0007281 | germ cell development | 0.0129699268652264 |
GO:0030427 | site of polarized growth | 0.0129699268652264 |
GO:0001935 | endothelial cell proliferation | 0.0129699268652264 |
GO:0033002 | muscle cell proliferation | 0.0129699268652264 |
GO:0051047 | positive regulation of secretion | 0.0129699268652264 |
GO:0004522 | pancreatic ribonuclease activity | 0.0129699268652264 |
GO:0042327 | positive regulation of phosphorylation | 0.0129699268652264 |
GO:0006638 | neutral lipid metabolic process | 0.0129699268652264 |
GO:0006639 | acylglycerol metabolic process | 0.0129699268652264 |
GO:0000267 | cell fraction | 0.0129699268652264 |
GO:0046486 | glycerolipid metabolic process | 0.0129699268652264 |
GO:0022601 | menstrual cycle phase | 0.0129699268652264 |
GO:0045937 | positive regulation of phosphate metabolic process | 0.0129699268652264 |
GO:0022602 | menstrual cycle process | 0.0129699268652264 |
GO:0006662 | glycerol ether metabolic process | 0.0129699268652264 |
GO:0006629 | lipid metabolic process | 0.0129699268652264 |
GO:0050708 | regulation of protein secretion | 0.0129699268652264 |
GO:0008585 | female gonad development | 0.0131258106267946 |
GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters | 0.0131258106267946 |
GO:0016877 | ligase activity, forming carbon-sulfur bonds | 0.0131258106267946 |
GO:0046660 | female sex differentiation | 0.0131258106267946 |
GO:0046545 | development of primary female sexual characteristics | 0.0131258106267946 |
GO:0016894 | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters | 0.013331151788889 |
GO:0030041 | actin filament polymerization | 0.0135291336434057 |
GO:0042698 | menstrual cycle | 0.0141484813821663 |
GO:0043025 | cell soma | 0.0144964345499042 |
GO:0007292 | female gamete generation | 0.0144964345499042 |
GO:0019843 | rRNA binding | 0.0146616763370218 |
GO:0005605 | basal lamina | 0.0160218026441832 |
GO:0017148 | negative regulation of translation | 0.0161569953268891 |
GO:0031327 | negative regulation of cellular biosynthetic process | 0.0166565806400099 |
GO:0005778 | peroxisomal membrane | 0.0166565806400099 |
GO:0048469 | cell maturation | 0.0166565806400099 |
GO:0031903 | microbody membrane | 0.0166565806400099 |
GO:0044439 | peroxisomal part | 0.016884205859888 |
GO:0044438 | microbody part | 0.016884205859888 |
GO:0001666 | response to hypoxia | 0.0169930388304039 |
GO:0009890 | negative regulation of biosynthetic process | 0.0176400003007381 |
GO:0048608 | reproductive structure development | 0.0176400003007381 |
GO:0008406 | gonad development | 0.0176400003007381 |
GO:0021700 | developmental maturation | 0.017732417975579 |
GO:0009306 | protein secretion | 0.0188107850763081 |
GO:0051046 | regulation of secretion | 0.0188545148732673 |
GO:0045137 | development of primary sexual characteristics | 0.0188545148732673 |
GO:0008154 | actin polymerization and/or depolymerization | 0.0188545148732673 |
GO:0048609 | reproductive process in a multicellular organism | 0.0188545148732673 |
GO:0032504 | multicellular organism reproduction | 0.0188545148732673 |
GO:0042325 | regulation of phosphorylation | 0.0195327876836674 |
GO:0051174 | regulation of phosphorus metabolic process | 0.0205421321007198 |
GO:0019220 | regulation of phosphate metabolic process | 0.0205421321007198 |
GO:0032147 | activation of protein kinase activity | 0.0205881552272556 |
GO:0004521 | endoribonuclease activity | 0.0209230556606885 |
GO:0005604 | basement membrane | 0.0210790797008298 |
GO:0009725 | response to hormone stimulus | 0.0210790797008298 |
GO:0008201 | heparin binding | 0.0210790797008298 |
GO:0051345 | positive regulation of hydrolase activity | 0.0210790797008298 |
GO:0007548 | sex differentiation | 0.0222101641048811 |
GO:0005741 | mitochondrial outer membrane | 0.0222338823698106 |
GO:0003006 | reproductive developmental process | 0.0233269439938313 |
GO:0007200 | G-protein signaling, coupled to IP3 second messenger (phospholipase C activating) | 0.0233379140418386 |
GO:0031968 | organelle outer membrane | 0.0243951342809688 |
GO:0007586 | digestion | 0.024636467903827 |
GO:0019867 | outer membrane | 0.024636467903827 |
GO:0051258 | protein polymerization | 0.024636467903827 |
GO:0042579 | microbody | 0.024636467903827 |
GO:0004540 | ribonuclease activity | 0.024636467903827 |
GO:0005777 | peroxisome | 0.024636467903827 |
GO:0051248 | negative regulation of protein metabolic process | 0.0253627177922908 |
GO:0005539 | glycosaminoglycan binding | 0.0265556523991351 |
GO:0030247 | polysaccharide binding | 0.0276913871447646 |
GO:0005507 | copper ion binding | 0.0276913871447646 |
GO:0001871 | pattern binding | 0.0296569389378297 |
GO:0048015 | phosphoinositide-mediated signaling | 0.0296569389378297 |
GO:0001525 | angiogenesis | 0.0296569389378297 |
GO:0044420 | extracellular matrix part | 0.0298335129112542 |
GO:0045860 | positive regulation of protein kinase activity | 0.0318041813116468 |
GO:0033674 | positive regulation of kinase activity | 0.0321800304860929 |
GO:0051347 | positive regulation of transferase activity | 0.0322556951144632 |
GO:0048514 | blood vessel morphogenesis | 0.0322556951144632 |
GO:0004519 | endonuclease activity | 0.032833695199742 |
GO:0048646 | anatomical structure formation | 0.032972222229306 |
GO:0005792 | microsome | 0.0339570459220793 |
GO:0001568 | blood vessel development | 0.0339570459220793 |
GO:0003012 | muscle system process | 0.0339570459220793 |
GO:0006936 | muscle contraction | 0.0339570459220793 |
GO:0005730 | nucleolus | 0.0339570459220793 |
GO:0001944 | vasculature development | 0.0339570459220793 |
GO:0042598 | vesicular fraction | 0.0342796057165606 |
GO:0006417 | regulation of translation | 0.0369973583403696 |
GO:0006631 | fatty acid metabolic process | 0.0380822101533051 |
GO:0031326 | regulation of cellular biosynthetic process | 0.0393454125919087 |
GO:0042277 | peptide binding | 0.0407823737579117 |
GO:0009889 | regulation of biosynthetic process | 0.0421954160278696 |
GO:0008285 | negative regulation of cell proliferation | 0.0433935348567793 |
GO:0008284 | positive regulation of cell proliferation | 0.0442238454679207 |
GO:0016477 | cell migration | 0.0442238454679207 |
GO:0045859 | regulation of protein kinase activity | 0.0446290798871913 |
GO:0043549 | regulation of kinase activity | 0.0450999918537434 |
GO:0004518 | nuclease activity | 0.0450999918537434 |
GO:0030036 | actin cytoskeleton organization and biogenesis | 0.0450999918537434 |
GO:0051338 | regulation of transferase activity | 0.0450999918537434 |
GO:0043085 | positive regulation of catalytic activity | 0.046382160641243 |
GO:0030029 | actin filament-based process | 0.0467524227931329 |
GO:0007276 | gamete generation | 0.0471170717781419 |
GO:0019932 | second-messenger-mediated signaling | 0.0474762305321381 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>
Ontology term | p-value | n |
---|---|---|
fat cell | 2.20e-08 | 15 |
Ontology term | p-value | n |
---|---|---|
multi-cellular organism | 2.87e-18 | 656 |
anatomical system | 4.92e-15 | 624 |
anatomical group | 1.04e-14 | 625 |
organ | 5.58e-12 | 503 |
multi-tissue structure | 1.06e-09 | 342 |
embryo | 1.44e-09 | 592 |
organism subdivision | 1.50e-09 | 264 |
developing anatomical structure | 7.08e-09 | 581 |
embryonic structure | 2.01e-08 | 564 |
germ layer | 6.48e-08 | 560 |
germ layer / neural crest | 6.48e-08 | 560 |
embryonic tissue | 6.48e-08 | 560 |
presumptive structure | 6.48e-08 | 560 |
germ layer / neural crest derived structure | 6.48e-08 | 560 |
epiblast (generic) | 6.48e-08 | 560 |
mesenchyme | 9.09e-08 | 160 |
entire embryonic mesenchyme | 9.09e-08 | 160 |
adult organism | 9.81e-08 | 114 |
trunk | 1.18e-07 | 199 |
endoderm-derived structure | 7.52e-07 | 160 |
endoderm | 7.52e-07 | 160 |
presumptive endoderm | 7.52e-07 | 160 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
MA0003.1 | 4.3611 |
MA0004.1 | 1.51734 |
MA0006.1 | 1.14863 |
MA0007.1 | 0.606704 |
MA0009.1 | 1.11255 |
MA0014.1 | 4.38573 |
MA0017.1 | 1.24112 |
MA0019.1 | 0.784036 |
MA0024.1 | 1.00439 |
MA0025.1 | 1.24931 |
MA0027.1 | 2.73598 |
MA0028.1 | 0.470679 |
MA0029.1 | 1.02437 |
MA0030.1 | 1.01252 |
MA0031.1 | 0.945567 |
MA0038.1 | 0.736268 |
MA0040.1 | 1.03042 |
MA0041.1 | 0.64667 |
MA0042.1 | 0.612397 |
MA0043.1 | 1.11288 |
MA0046.1 | 1.10134 |
MA0048.1 | 1.7027 |
MA0050.1 | 0.613347 |
MA0051.1 | 0.731787 |
MA0052.1 | 1.03442 |
MA0055.1 | 1.01397 |
MA0056.1 | 0 |
MA0057.1 | 0.189508 |
MA0058.1 | 1.29981 |
MA0059.1 | 0.522232 |
MA0060.1 | 0.321781 |
MA0061.1 | 0.291022 |
MA0063.1 | 0 |
MA0066.1 | 0.736721 |
MA0067.1 | 1.43651 |
MA0068.1 | 0.247962 |
MA0069.1 | 1.09737 |
MA0070.1 | 1.08584 |
MA0071.1 | 0.695094 |
MA0072.1 | 1.0812 |
MA0073.1 | 0.362215 |
MA0074.1 | 0.730989 |
MA0076.1 | 0.540943 |
MA0077.1 | 1.07324 |
MA0078.1 | 0.836493 |
MA0081.1 | 0.522409 |
MA0083.1 | 1.12028 |
MA0084.1 | 1.62584 |
MA0087.1 | 1.07867 |
MA0088.1 | 0.132006 |
MA0089.1 | 0 |
MA0090.1 | 0.556637 |
MA0091.1 | 0.629594 |
MA0092.1 | 0.588959 |
MA0093.1 | 2.99362 |
MA0095.1 | 0 |
MA0098.1 | 0 |
MA0100.1 | 1.77562 |
MA0101.1 | 0.459973 |
MA0103.1 | 0.442769 |
MA0105.1 | 0.175503 |
MA0106.1 | 0.779931 |
MA0107.1 | 0.378225 |
MA0108.2 | 0.94238 |
MA0109.1 | 0 |
MA0111.1 | 0.5713 |
MA0113.1 | 0.797251 |
MA0114.1 | 0.372523 |
MA0115.1 | 1.35895 |
MA0116.1 | 0.382106 |
MA0117.1 | 1.1512 |
MA0119.1 | 0.504689 |
MA0122.1 | 1.17777 |
MA0124.1 | 1.31673 |
MA0125.1 | 1.23103 |
MA0130.1 | 0 |
MA0131.1 | 0.855546 |
MA0132.1 | 0 |
MA0133.1 | 0 |
MA0135.1 | 1.14377 |
MA0136.1 | 0.743749 |
MA0139.1 | 0.277033 |
MA0140.1 | 0.692258 |
MA0141.1 | 0.520334 |
MA0142.1 | 0.912455 |
MA0143.1 | 0.797437 |
MA0144.1 | 0.356507 |
MA0145.1 | 0.442008 |
MA0146.1 | 0.946108 |
MA0147.1 | 1.77656 |
MA0148.1 | 0.653474 |
MA0149.1 | 0.681935 |
MA0062.2 | 0.284987 |
MA0035.2 | 0.691506 |
MA0039.2 | 2.38271 |
MA0138.2 | 0.837782 |
MA0002.2 | 0.30855 |
MA0137.2 | 0.47779 |
MA0104.2 | 0.858845 |
MA0047.2 | 0.767096 |
MA0112.2 | 0.136971 |
MA0065.2 | 0.880827 |
MA0150.1 | 0.550239 |
MA0151.1 | 0 |
MA0152.1 | 0.69926 |
MA0153.1 | 1.21379 |
MA0154.1 | 1.57192 |
MA0155.1 | 0.813062 |
MA0156.1 | 0.480289 |
MA0157.1 | 0.883854 |
MA0158.1 | 0 |
MA0159.1 | 0.386729 |
MA0160.1 | 0.669748 |
MA0161.1 | 0 |
MA0162.1 | 0.0592265 |
MA0163.1 | 0.382496 |
MA0164.1 | 0.810347 |
MA0080.2 | 0.456437 |
MA0018.2 | 0.781393 |
MA0099.2 | 0.699641 |
MA0079.2 | 2.12087 |
MA0102.2 | 1.66336 |
MA0258.1 | 0.345771 |
MA0259.1 | 1.02361 |
MA0442.1 | 0 |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
E2F1#1869 | 4 | 3.92591137190346 | 0.00721498454710636 | 0.0298745498598597 |
ZNF263#10127 | 4 | 6.57747330960854 | 0.000987510323790016 | 0.00709072469620526 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data
This analysis result is provided for C0 - C305 clusters.